Business Context and Reporting Period
This Form 10-Q covers the quarterly period ended March 31, 1998, for Dauphin Technology, Inc. (Note: The input metadata lists "Geovax Labs, Inc.", but the filing text explicitly identifies the registrant as Dauphin Technology, Inc.). The Company designs, manufactures, and markets mobile computing systems and components. In June 1997, Dauphin acquired R.M. Schultz & Associates, Inc. (RMS), an electronics contract manufacturing firm, which is now a wholly-owned subsidiary. The Company is currently in the pre-production phase of its flagship product, the "Orasis" hand-held computer.
Key Financial Metrics
| Metric | Q1 1998 | Q1 1997 |
|---|---|---|
| Net Sales | $1,456,522 | $22,317 |
| Gross Profit | $220,843 | $9,112 |
| Gross Margin | 15.2% | 40.8% |
| Net Loss | $(875,170) | $(326,631) |
| Loss Per Share (Basic/Diluted) | $(0.03) | $(0.01) |
| Cash and Equivalents (End of Period) | $1,918,182 | $144,383 |
| Total Assets | $6,095,485 | N/A (Not provided in text for Q1 1997) |
| Total Liabilities | $1,236,466 | N/A |
| Shareholders' Equity | $4,859,020 | N/A |
Operating Expenses: Selling, General, and Administrative (SG&A) expenses were $563,684. Research and Development (R&D) expenses were $555,027.
Cash Flow: Net cash used in operating activities was $1,292,799. Net cash used in investing activities was $383,707 (primarily for property and equipment). Net cash provided by financing activities was $(26,192).
Material Changes vs. Prior Period
- Revenue Surge: Net sales increased dramatically from $22,317 in Q1 1997 to $1,456,522 in Q1 1998. This growth is attributed to the inclusion of RMS operations following the June 1997 acquisition.
- Expense Growth: SG&A expenses rose from $335,734 to $563,684 due to increased headcount (from 12 to ~100 employees) and trade show spending. R&D expenses jumped from $3,852 to $555,027, driven by the development of the Orasis product.
- Widened Loss: Despite higher revenue, the net loss more than doubled to $(875,170) due to the significant increase in operating expenses and R&D investment.
- Liquidity Position: Cash balances decreased from $3,620,880 at December 31, 1997, to $1,918,182 at March 31, 1998, a reduction of approximately $1.7 million, primarily due to R&D expenditures, inventory buildup for Orasis, and repayment of current liabilities.
Guidance, Outlook, and Risks
- Product Launch: Management expects sales of the Orasis hand-held computer to begin late in the second quarter of 1998. Cash flow from these sales is expected to fund future working capital and R&D.
- Capital Requirements: The Company anticipates additional cash needs in Q2 1998 to fund early production steps. Management plans to pursue additional operating capital, potentially through a credit facility.
- Recent Financing: Subsequent to the period end, on May 13, 1998, the Company issued 8% Convertible Subordinated Debentures totaling up to $1,000,000 due in 2001. These can be converted to common stock.
- Legal Contingency: The Company is involved in a wrongful discharge lawsuit filed on April 11, 1998, by an ex-employee/officer. Management believes the liability, if any, will not be material.
- Commitments: The Company has a commitment of $521,250 for industrial molds for the Orasis, partially paid in cash and partially via stock issuance.
Investor Verification Checklist
- Verify the timeline for the commercial launch of the "Orasis" product and the associated revenue recognition assumptions.
- Confirm the sufficiency of the $1.9 million cash balance to sustain operations through the production phase of Orasis without immediate dilution or additional debt.
- Review the terms of the $1,000,000 Convertible Debentures issued in May 1998, specifically the conversion formula and warrant exercise prices.
- Monitor the status of the wrongful discharge lawsuit filed in April 1998 to ensure no material liability emerges.
- Assess the gross margin sustainability of the RMS contract manufacturing business versus the projected margins for the Orasis product.